Cyberdyne Inc. · TSE:7779

Cyberdyne — H1 FY2026 Earnings Presentation

33 slides from Cyberdyne's earnings presentation, Nov 13, 2025

  1. Slide 1: CYBERDYNE FY2026 interim results supplementary materials

    2026 3 CYBERDYNE 2025 11 13

  2. Slide 2: CYBERDYNE

    CYBERDYNE

  3. Slide 3: FY2026 1H results highlights (IFRS)

    2026 3 1H - (IFRS ) Q1 ( : ) 2024/1H 2025/1H 2,143 1,963 179 8.4% 497 174 + 323 - 215 297 + 512 - 305 70 + 375 - ( ) EMEA +107 ( +108 1 ) 1,963 APAC +90 ( +107 16 ) 124 ( 88 37 ) 179 ( 8.4%) : LeyLine 220 32 EMEA +78 ( +79 1 ) 174 APAC +84 ( +94 10 ) +17 ( +14 +2 ) +323 : LeyLine +153 +23 R&D 31 +32

  4. Slide 4: Results by product and region

    / EMEA APAC RHG LeyLine ( : ) 2024/1H 2025/1H 832 1,030 +198 +24% ( %) 333 (40%) 495 (48%) +162 (+8pt) +49% 946 822 124 13% ( %) 62 ( 7%) 46 ( 6%) +16 (+1pt) - 365 112 253 69% ( %) 170 ( 47%) 6 (6%) +176 (+53pt) - RD 598 630 32 - 2,143 1,963 179 8% ( %) 497 ( 23%) 174 ( 9%) +323 (+14pt) - (IFRS ) •

  5. Slide 5: Revenue by region: EMEA, APAC, AMER

    ( : ) 2025 EMEA APAC AMER ( 2024 ) 488 245 277 20 1,030 +198 (456) (137) (220) (19) (832) (+24%) 62 33 726 822 124 (63) (21) - (862) (946) ( 13%) 112 - ※ 112 253 (144) (220) - - (365) ( 69%) 662 278 277 746 1,963 179 (663) (379) (220) (880) (2,143) ( 8%) 1 101 +57 136 ( 0%) ( 27%) (+26%) ( 15%) 34%

  6. Slide 6: HAL revenue by product

    - HAL ( ) ( : ) 2025 ( 2024 ) HAL 210 385 595 (183) (268) (450) HAL 76 - 76 (80) (80) HAL 48 75 123 (44) (52) (96) HAL 40 58 98 (51) (43) (95) HAL 18 - 18 (19) (19) (CL02 ) 51 - 51 (39) (39) Acoustic X 45 24 69 (41) (13) (54) 488 542 1,030 (456) (376) (832)

  7. Slide 7: CYBERDYNE

    CYBERDYNE

  8. Slide 8: Society 5.0/5.1

    Society Society Society Society Society 5.0/5.1 1.0 2.0 3.0 4.0

  9. Slide 9: AI and cyber-physical technology

    Ditty k * Al Cybernics " FINDA) Al Al Ditty b ER IRR? Al FIRST ImPACT SIP

  10. Slide 10: Product lineup

    ib Type ability te Medical HAL Single Joint Type Flexible product that can Cleaning Robot HAL Lumbar Type fo! ‘Autonomous robe i Well-being @R product that the next level supports both ‘Transportation Robot Autonomous robot that can BPO - Sei kSeHEA LE Medial HAL Single Joint Well-being A product th

  11. Slide 11: Pre-Hospital, Hospital, Post-Hospital

    Pre-Hospital Hospital Post-Hospital

  12. Slide 12: Actively controlled exoskeletons show improved function: systematic review

    AO Review Artie SPINE ‘lea! Sin Jour Actively Controlled Exoskeletons Show Sinai) ae Improved Function and Neuroplasticity septccel eerie Fourndssagptb consort Compared to Passive Control: A Systematic Qereenorve Review Ka loi Ar, James Gi and Darren} Abstract Study Design: Systematic Review. Object

  13. Slide 13: Cerebral correlates of robot-assisted upper limb motion: fNIRS study

    IEEE TRANSACTIONS ON NEURAL SYSTEMS AND PEHABILITATION ENGINEERING, VOL. 98, 2025 EMBS Cerebral Correlates of Robot-Assisted Upper Limb Motion Driven by Motor Intention in Healthy Individuals: An fNIRS Study Margaux Noémie Lafitte”, Christina Sylvia Andrea, Hideki Kadone®, Elichi Hoshino, Mesashi Ya

  14. Slide 14: edt

    edt Seer eter

  15. Slide 15: RAO RBE

    RAO RBE PBRCOSE OY s-yamcemens ER/NILATPOMIS RIROATO

  16. Slide 16: Slide 16

  17. Slide 17: LED photoacoustic imaging

    |) BIOPHOTONIGS SINGIN LICH Ta MEeE SCIENCES — > LEDS tieip to Pi Diseased Tissue

  18. Slide 18: CYBERDYNE

    CYBERDYNE

  19. Slide 19: Cabinet Office SIP program

    (SIP) 1) 2) ( ) HCPS ( ) 3) HCPS 4)

  20. Slide 20: Slide 20

  21. Slide 21: HCPS and AI

    Karor enn WER SO} ARSC ROL VEBRKUERADC? SE APa nea 2 phe BY BE REBOX + ERCopamma>zey DRALU BSH (YZ —bYA) BX bdS-MER EY” RAY <EUER <SSAUEPneRBA DK ABR CORRE 96) KODp’ OVCRHNHEREPO RAAT RQ’ Hh: BK AP ERUERP OREO MEE im we? [EBA PRES DIRE IRI NOE! CHVEDERRR) RY BRODY UELURROMEVER BX EW) VSS’ aUENOAAY<I

  22. Slide 22: CYBERDYNE

    CYBERDYNE

  23. Slide 23: EU, EMEA, APAC expansion; HTLV-1 HAM

    HTLV-1 HAM HTLV-1 HAM EU EMEA APAC

  24. Slide 24: HTLV-1

    Qereerarwe 2024/5 HTLV-1

  25. Slide 25: G-BA trial regulation timeline

    G-BA 2023/01 2023/03 2023/09 2024/11 CRO G-BA (Federal Joint Committee, ) §137e SGB V Trial Regulation: : G-BA CRO: (Contract Research Organization)

  26. Slide 26: CYBERDYNE

    CYBERDYNE

  27. Slide 27: / / /

    / / /

  28. Slide 28: Slide 28

  29. Slide 29: HAL: Socso urged to build three new rehabilitation centres

    HAL 14 Socso urged to build three new rehabilitation centres in five years ‘Singapore. Balan,

  30. Slide 30: Slide 30

  31. Slide 31: Bs yt

    Bs yt ara aa vas n-Chang Chen, NTU sident Wel

  32. Slide 32: JICA and HAL

    ) fisg ok mann DAING HRB Tq} asVE 23R3 be< aya PXHHEA Se teed Zitou RERIDKALERS | EoBoocolke” 5] pie EN BOHOR| ee we] Or meay ze (b] MUCBEPEBIN/ EY QUES CRW | Ee L Vk-aW) Sn’ | POOR BERR | INA POmeiam| m<A Tl SN TRUER | Bboy’ A—DOMMBR DER | pug YER [r<] SHO mLAOD AN WECNSIOY YX —| SBS J REX POR | TH

  33. Slide 33: CYBERDYNE

    Qoreerorve

Cyberdyne — H1 FY2026 Earnings Presentation on 6ix